open access

Vol 12, No 3 (2017)
Case Reports
Published online: 2017-06-30
Get Citation

Pulmonary embolism in 21-year-old childless woman — treatment in the area of new oral anticoagulants

Marta Drankowska, Elżbieta Malarkiewicz, Agnieszka Słowińska
DOI: 10.5603/FC.2017.0056
·
Folia Cardiologica 2017;12(3):291-294.

open access

Vol 12, No 3 (2017)
Case Reports
Published online: 2017-06-30

Abstract

Pulmonary embolism (PE) is an acute condition that requires rapid diagnosis and immediate treatment. Basic treatment
of PE is anticoagulant — both parenteral and oral. In initial treatment heparin (fractionated or low-molecular weight) is
used, followed by oral medications. More and more often treatment is continued with new oral anticoagulants (NOAC),
which are as effective as vitamin antagonists K, but do not need to monitor the international normalized factor. Currently, due to lack of randomized studies, NOAC is not recommended for pregnant women. In this paper the authors are pondering over the choice of treatment method in young childbearing woman of childbearing age with recognized PE.

Abstract

Pulmonary embolism (PE) is an acute condition that requires rapid diagnosis and immediate treatment. Basic treatment
of PE is anticoagulant — both parenteral and oral. In initial treatment heparin (fractionated or low-molecular weight) is
used, followed by oral medications. More and more often treatment is continued with new oral anticoagulants (NOAC),
which are as effective as vitamin antagonists K, but do not need to monitor the international normalized factor. Currently, due to lack of randomized studies, NOAC is not recommended for pregnant women. In this paper the authors are pondering over the choice of treatment method in young childbearing woman of childbearing age with recognized PE.

Get Citation

Keywords

NOAC, pulmonary embolism

About this article
Title

Pulmonary embolism in 21-year-old childless woman — treatment in the area of new oral anticoagulants

Journal

Folia Cardiologica

Issue

Vol 12, No 3 (2017)

Pages

291-294

Published online

2017-06-30

DOI

10.5603/FC.2017.0056

Bibliographic record

Folia Cardiologica 2017;12(3):291-294.

Keywords

NOAC
pulmonary embolism

Authors

Marta Drankowska
Elżbieta Malarkiewicz
Agnieszka Słowińska

References (7)
  1. Bednarz B, Biederman A, Budaj A. Zakrzepy i zatory. Wydawnictwo Lekarskie PZWL, Warszawa 214.
  2. Chan WS, Rey E, Kent NE, et al. VTE in Pregnancy Guideline Working Group, Society of Obstetricians and Gynecologists of Canada. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014; 36(6): 527–553.
  3. Dahlman TC, Hellgren MS, Blombäck M. Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma. Am J Obstet Gynecol. 1989; 161(2): 420–425.
  4. Frołow M. Kto jest zagrożony zakrzepicą? https://zakrzepica.mp.pl/wszystkoozakrzepicy/profilaktyka/55428,kto-jest-zagrozony-zakrzepica. (July 27th 2016).
  5. Hoeltzenbein M, Beck E, Meixner K, et al. Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre. Clin Res Cardiol. 2016; 105(2): 117–126.
  6. Karthikeyan G, Eikelboom JW, Hirsh J. Nowe doustne antykoagulanty — jeszcze nie koniec drogi. Pol Arch Med Prakt. 2000; 119(1–2. : 1–6.
  7. Szczeklik A, Gajewski P. Interna Szczeklika Podręcznik chorób wewnętrznych. Wyd. 7. Medycyna Praktyczna, Kraków .

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl